Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
LOS ANGELES--(BUSINESS WIRE)---- $CCXI #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on be
NEW YORK, May 10, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of ChemoCentryx,
BENSALEM, Pa.--(BUSINESS WIRE)---- $CCXI #CLASSACTION--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased ChemoCentryx, Inc. (“C
ChemoCentryx: CRL Likely
12:27pm, Sunday, 09'th May 2021
After a critical FDA briefing doc, the advisory committee split 9-9 on efficacy, 10-8 on safety and risk-benefit. This tells me a CRL is likely because the FDA has no reason to go against its own brie
Radnor, Pennsylvania--(Newsfile Corp. - May 8, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against ChemoCen
CCXI INVESTORS ACT NOW: Contact HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, to Recover Losses Due to Alleged Securities Fraud
07:05pm, Friday, 07'th May 2021
San Francisco, California--(Newsfile Corp. - May 7, 2021) - Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class
New York, New York--(Newsfile Corp. - May 7, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Chem
LOS ANGELES--(BUSINESS WIRE)---- $CCXI #investors--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of ChemoCentryx, Inc. (CCXI) Investors
SHAREHOLDER ALERT: Robbins LLP Announces That ChemoCentryx, Inc. (CCXI) is Being Sued for Misleading Shareholders
04:52pm, Friday, 07'th May 2021
SAN DIEGO & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $CCXI--Shareholder rights law firm Robbins LLP announces that a purchaser of ChemoCentryx, Inc. (NASDAQ: CCXI) filed a class action complaint aga
RADNOR, Pa.--(BUSINESS WIRE)---- $CCXI #classaction--Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc.
Here's why ChemoCentryx plunged 60% in the stock market on Friday
01:50pm, Friday, 07'th May 2021
ChemoCentryx Inc (NASDAQ: CCXI) tanked roughly 60% in the stock market on Friday as approval for its drug for an autoimmune disease hung in the balance. ChemoCentryx is seeking FDA approval for Avacop
Why ChemoCentryx Stock Is Cratering Again Today
12:22pm, Friday, 07'th May 2021
Investors aren't optimistic after an FDA advisory committee vote for avacopan.
Los Angeles, California--(Newsfile Corp. - May 7, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ChemoCentryx, Inc. ("C
Why ChemoCentryx Shares Are Plunging Today
10:41am, Friday, 07'th May 2021
ChemoCentryx (NASDAQ: CCXI) shares are trading lower following a vote from the FDA panel on whether the efficacy data support approval on its Avacopan in ANCA-Associated vasculitis. The vote on wheth
Analysts React To FDA AdCom Vote On ChemoCentryx's Avacopan, Stock Plunges
10:17am, Friday, 07'th May 2021
Yesterday, the FDA's Arthritis Advisory Committee panelists went through cloudy data while complaining about the design of the Phase 3 trial for ChemoCentryx Inc's (NASDAQ: CCXI) avacopan. After go
